These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 2872117)

  • 61. Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children.
    Morgan CM; Blumberg DA; Cherry JD; Reisinger KS; Blatter MM; Blumer JL; Dekker CL; Stout MG; Christenson PD
    Am J Dis Child; 1990 Jan; 144(1):41-5. PubMed ID: 2403747
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Study on immune persistency of combined diphtheria-pertussis-tetanus (DPT) triple vaccine].
    Diao L
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Feb; 13(1):26-9. PubMed ID: 1581951
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adverse reactions to diphtheria, tetanus, pertussis-polio vaccination at 18 months of age: effect of injection site and needle length.
    Ipp MM; Gold R; Goldbach M; Maresky DC; Saunders N; Greenberg S; Davy T
    Pediatrics; 1989 May; 83(5):679-82. PubMed ID: 2717284
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical and serologic responses to acellular pertussis vaccine in infants and young children.
    Anderson EL; Belshe RB; Bartram J; Gurwith M; Hung P; Levner M; Vernon SK
    Am J Dis Child; 1987 Sep; 141(9):949-53. PubMed ID: 3618569
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inadvertent administration of DTP and DT after age six as recorded in the Vaccine Adverse Event Reporting System.
    Zimmerman RK; Pellitieri TR
    Fam Pract Res J; 1994 Dec; 14(4):353-8. PubMed ID: 7863807
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunizations, seizures, and subsequent evaluation.
    Barkin RM; Jabhour JT; Samuelson JS
    JAMA; 1987 Jul; 258(2):201. PubMed ID: 3496471
    [No Abstract]   [Full Text] [Related]  

  • 67. Association of reactions after consecutive acellular or whole-cell pertussis vaccine immunizations.
    Deloria MA; Blackwelder WC; Decker MD; Englund JA; Steinhoff MC; Pichichero ME; Rennels MB; Anderson EL; Edwards KM
    Pediatrics; 1995 Sep; 96(3 Pt 2):592-4. PubMed ID: 7659483
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessing the impact of the expanded programme on immunization: the example of Indonesia.
    Kim-Farley R; Soewarso TI; Karyadi A; Adhyatma M
    Bull World Health Organ; 1987; 65(2):203-6. PubMed ID: 3496986
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Response of preterm infants to diphtheria-tetanus-pertussis vaccine.
    Koblin BA; Townsend TR; Muñoz A; Onorato I; Wilson M; Polk BF
    Pediatr Infect Dis J; 1988 Oct; 7(10):704-11. PubMed ID: 3263614
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum antibodies to diphtheria-tetanus-pertussis vaccine components in Argentine children.
    Pasetti M; Eriksson P; Ferrero F; Manghi M
    Infection; 1997; 25(6):339-45. PubMed ID: 9427051
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pertussis vaccine.
    Few BJ
    MCN Am J Matern Child Nurs; 1987; 12(4):243. PubMed ID: 3112494
    [No Abstract]   [Full Text] [Related]  

  • 72. Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody.
    Blumberg DA; Mink CM; Cherry JD; Reisinger KS; Blatter MM; Congeni BL; Dekker CL; Stout MG; Mezzatesta JR; Scott JV
    J Pediatr; 1990 Jul; 117(1 Pt 1):46-51. PubMed ID: 2196360
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acetaminophen prophylaxis of adverse reactions following vaccination of infants with diphtheria-pertussis-tetanus toxoids-polio vaccine.
    Ipp MM; Gold R; Greenberg S; Goldbach M; Kupfert BB; Lloyd DD; Maresky DC; Saunders N; Wise SA
    Pediatr Infect Dis J; 1987 Aug; 6(8):721-5. PubMed ID: 3313232
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Defining the key parameters for comparing reactions among acellular and whole-cell pertussis vaccines.
    Pichichero ME; Christy C; Decker MD; Steinhoff MC; Edwards KM; Rennels MB; Anderson EL; Englund JA
    Pediatrics; 1995 Sep; 96(3 Pt 2):588-92. PubMed ID: 7659482
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Why wait for DTP-E-IPV?
    Marcuse EK
    Am J Dis Child; 1989 Sep; 143(9):1006-7. PubMed ID: 2788991
    [No Abstract]   [Full Text] [Related]  

  • 76. [Experience of the People's Republic of Bulgaria in controlling diphtheria, tetanus and whooping cough].
    Polikar ACh; Solomonova KM; Mikhaĭlova VP
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):92-6. PubMed ID: 3874506
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Recurrent seizures after diphtheria, tetanus, and pertussis vaccine immunization. Onset less than 24 hours after vaccination.
    Murphy JV; Sarff LD; Marquardt KM
    Am J Dis Child; 1984 Oct; 138(10):908-11. PubMed ID: 6206715
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunization of children who have received fractional doses of diphtheria-tetanus toxoids-pertussis vaccine.
    Pediatr Infect Dis J; 1989 Feb; 8(2):129-30. PubMed ID: 2704606
    [No Abstract]   [Full Text] [Related]  

  • 79. [The relationships between antitoxic titers determined in a group of young people before and after booster ADT by the in vivo neutralization test. Comparative NT-PHAR evaluations].
    Durbacă S; Stoean C; Mateescu M
    Arch Roum Pathol Exp Microbiol; 1989; 48(2):135-46. PubMed ID: 2561337
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Local adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine, adsorbed, in Surrey, BC.
    CMAJ; 1989 Aug; 141(4):312-3. PubMed ID: 2527591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.